Original Source(s)
Related Content
The Bill Nobody's Discussing in the Exam Room
Head and neck cancer costs are crushing patients — yet cost discussions remain uncommon in clinical care.
by Kerri Miller
May 11, 2026
-
2 min
Neoadjuvant Chemo Did Not Improve Disease-Free Survival
Phase 3 NeoCol trial adds to mixed evidence as field shifts toward biomarker-guided approaches
May 1, 2026
-
5 min